Case study of primary imatinib resistance and correlation of BCR-ABL multiple mutations in chronic myeloid leukemia

By Iqbal Zafar   Siddiqui Rubina T   Qureshi Javed A   Khalid Ahmad M  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 249-254

Future Medicine

Access to resources Recommend Favorite

Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-07 ,pp. : 11-16

Karger

Access to resources Recommend Favorite

Combination of EUTOS score and 3‐month BCR‐ABL transcript level identifies a group of good‐risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : E135-E137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hyperdiploidy Associated with a High BCR-ABL Transcript Level May Identify Patients at Risk of Progression in Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 7-9

Karger

Access to resources Recommend Favorite

International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-01 ,pp. : 135-142

Karger

Access to resources Recommend Favorite